Status
Conditions
Treatments
About
This study could help identify aggravating or protective genetic polymorphisms associated with cerebral palsy. Populations of premature babies at different risk of cerebral palsy could thus be individualized with an impact on their monitoring and on the pathophysiological understanding of the processes leading to neurological lesions.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
27 participants in 2 patient groups
Loading...
Central trial contact
Cyril Flamant, Pr; Jean-Christophe Roze, Pr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal